Predictive genomics DNA profiling for athletic performance

Recent Patents on DNA and Gene Sequences

Volumn 6, Issue 3, 2012, Pages 229-239

  Kambouris, Marios ^a,b,c   Ntalouka, Foteini ^c   Ziogas, Georgios ^d   Maffulli, Nicola ^e  

^a Shafallah Medical Genetics Center   (Qatar)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Gonidio LTD   (Cyprus)

^d Sports Clinic   (Greece)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

DNA profiling; Individualized training; Personalized nutrition; Predictive genomics; Sports performance

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 5; CREATINE KINASE MM; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE; ERYTHROPOIETIN RECEPTOR; FOLIC ACID; GENOMIC DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; LACTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PYRIDOXINE; STROMELYSIN; TESTOSTERONE; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VITAMIN D RECEPTOR;

ANGIOGENESIS; ARTICLE; ATHLETE; ATHLETIC PERFORMANCE; BLOOD PRESSURE; BODY COMPOSITION; BODY WEIGHT; BONE INJURY; CLINICAL LABORATORY; DIET SUPPLEMENTATION; DNA SEQUENCE; DOPING; DRUG MONITORING; ERYTHROCYTE; EXERCISE; GENETIC ALGORITHM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOMICS; GENOTYPE; HEALTH PROMOTION; HEART RATE; HEMOCHROMATOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METHODOLOGY; MOLECULAR BIOLOGY; MOTIVATION; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE METABOLISM; MUSCLE STRENGTH; NUTRITION; PATENT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; SKELETAL MUSCLE; SOFT TISSUE INJURY; SPORT; SPORT INJURY; STRESS MANAGEMENT; SUBSTANCE ABUSE; TENDINITIS; TRAINING; URINALYSIS; VASODILATATION;

EID: 84867814106     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221512802717321     Document Type: Article

References (61)

1. MacArthur DG, North KN: Genes and human elite athletic performance. Hum Genet 2005; 116: 331-339.
2. Lippi G, Longo UG, Maffulli N. Genetics and sports. Br Med Bull 2010; 93 (1): 27-47.
3. Brutsaert TD, Parra EJ. What makes a champion? Explaining variation in human athletic performance. Respir Physiol Neurobiol 2006; 151:109-123.
4. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999; 87(4):1313-6.
5. Woods DR, Humphries SE, Montgomery HE. The ACE I/D polymorphism and human physical performance. Trends Endocrinol Metab 2000; 11(10):416-20.
6. Van Guilder GP, Pretorius M, Luther JM, et al. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition. Hypertension 2008; 51(2):454-9.
7. Williams AG, Dhamrait SS, Wootton PT, et al. Bradykinin receptor gene variant and human physical performance. J Appl Physiol 2004; 96(3):938-42.
8. Saunders CJ, Xenophontos SL, Cariolou MA, Anastassiades LC, Noakes TD, Collins M. The bradykinin beta 2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons. Hum Mol Genet 2006; 15(6):979-87.
9. Mason SD, Rundqvist H, Papandreou I, et al. HIF-1alpha in endurance training: suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol 2007; 293(5): 2059-69.
10. Kraus RM, Stallings HW 3rd, Yeager RC, Gavin TP. Circulating plasma VEGF response to exercise in sedentary and endurancetrained men. J Appl Physiol 2004; 96(4):1445-50.
11. Prior SJ, Hagberg JM, Paton CM, et al. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol Heart Circ Physiol 2006; 290(5): H1848-55.
12. Gregory D. Longmore. Erythropoietin receptor mutations and Olympic glory. Nature Genetics 1993; 4: 108-110.
13. Linda S. Pescatello, Steven M. Roth. Exercise Genomics. New York: Springer; 2011.
14. de la Chapelle A, Träskelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993; 90(10): 4495-4499.
15. He Z, Hu Y, Feng L, et al. Polymorphisms in the HBB gene relate to individual cardiorespiratoryadaptation in response to endurance training. Br J Sports Med 2006; 40: 998-1002.
16. Hautala AJ, Rankinen T, Kiviniemi AM, et al. Heart rate recovery after maximal exercise is associated with acetylcholine receptor M2 (CHRM2) gene polymorphism. Am J Physiol Heart Circ Physiol 2006; 291(1): H459-66.
17. Lucia A, Gómez-Gallego F, Barroso I, Rabadán M, Bandrés F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ, Franks PW. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl 2005; 99(1): 344-8.
18. Calvo JA, Daniels TG, Wang X, et al. Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol 2008; 104(5): 1304-12.
19. Echegaray M, Rivera MA. Role of creatine kinase isoenzymes on muscular and cardiorespiratory endurance: genetic and molecular evidence. Sports Med 2001; 31(13):919-34.
20. Zhou DQ, Hu Y, Liu G, Gong L, Xi Y, Wen L. Muscle-specific creatine kinase gene polymorphism and running economy responses to an 18-week 5000-m training programme. Br J Sports Med 2006; 40(12):988-91.
21. Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005; 13(8):965-9.
22. MacArthur DG, Seto JT, Chan S, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alphaactinin-3 deficiency and human athletic performance. Hum Mol Genet 2008; 17(8):1076-86.
23. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001 Jan 1;29(1):308-11. Database of Single Nucleotide Polymorphisms (dbSNP). Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine. (dbSNP Build ID: {build ID}). Available from: http://www.ncbi.nlm.nih.gov/SNP/
24. Eynon N, Alves AJ, Meckel Y, et al. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance? Metabolism 2010; 59(6):861-5.
25. Bray MS, Hagberg JM, Pérusse L, et al. The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 2009; 41(1):35-73.
26. Rubio JC, Martín MA, Rabadán M, et al. Frequency of the C34T genomic varant of the AMPD1 gene in world-class endurance athletes: does this genomic variant impair performance? J Appl Physiol 2005; 98(6):2108-12.
27. Cupeiro R, Benito PJ, Maffulli N, Calderón FJ, González-Lamuño D. MCT1 genetic polymorphism influence in high intensity circuit training: a pilot study. J Sci Med Sport 2010; 13(5):526-30.
28. Peeters RP, van den Beld AW, van Toor H, et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J Clin Endocrinol Metab 2005; 90(1):256-63.
29. Collins M, Posthumus M, Schwellnus MP. The COL1A1 gene and acute soft tissue ruptures. Br J Sports Med 2010; 44(14):1063-4.
30. Posthumus M, September AV, Keegan M, et al. Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. Br J Sports Med 2009; 43(5):352-6.
31. September AV, Cook J, Handley CJ, van der Merwe L, Schwellnus MP, Collins M. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009; (5):357-65.
32. Mokone GG, Schwellnus MP, Noakes TD, Collins M. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006; 16(1):19-26.
33. Raleigh SM, van der Merwe L, Ribbans WJ, Smith RK, Schwellnus MP, Collins M. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med 2009; 43(7):514-20.
34. Nakamura O, Ishii T, Ando Y, et al. Potential role of vitamin D receptor gene polymorphism in determining bone phenotype in young male athletes. J Appl Physiol 2002; 93(6):1973-9, 2002.
35. Heini Hartikka. Genetic Factors In Bone Disorders: Osteogenesis Imperfecta, Juvenile Osteoporosis And Stress Fractures [PhD thesis]. University of Oulu, Finland; 2005.
36. Abrams SA, Griffin IJ, Hawthorne KM, et al. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J Bone Miner Res 2005; 20(6):945-53.
37. Lima JJ, Feng H, Duckworth L, et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 2007; 56(6):757-65.
38. Rosmond R, Bouchard C, Björntorp P. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med 2002; 251(3):252-7.
39. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML. Beta2-and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 111(25):3429-34.
40. Park HS, Kim Y, Lee C. Single nucleotide variants in the beta2-adrenergic and beta3-adrenergic receptor genes explained 18.3% of adolescent obesity variation. J Hum Genet 2005; 50(7):365-9.
41. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity. Obes Res 2005; 13(3):519-26.
42. Bryan A, Hutchison KE, Seals DR, Allen DL. A transdisciplinary model integrating genetic, physiological, and psychological correlates of voluntary exercise. Health Psychol 2007; 26(1):30-9.
43. Chen ZY, Jing D, Bath KG, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314(5796):140-3.
44. Jakobsson J, Ekström L, Inotsume N, et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyltransferase 2B17 polymorphism. J Clin Endocrinol Metab 2006; 91(2):687-93.
45. Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, Rane A. Doping test results dependent on genotype of uridinediphosphoglucuronosyltransferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 2008; 93(7):2500-6.
46. Boehl T. Emerging science raises questions: what to tell your clients about nutritional genomics. J Am Diet Assoc 2007; 107(7):1094-6.
47. Stover PJ, Caudill MA. Genetic and epigenetic contributions to human nutrition and health: managing genome-diet interactions. J Am Diet Assoc 2008; 108(9):1480-7.
48. DeBusk RM, Fogarty CP, Ordovas JM, Kornman KS. Nutritional genomics in practice: where do we begin? J Am Diet Assoc 2005; 105(4):589-98.
49. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22(4):195-201.
50. Lu C, Xie H, Wang F, Shen H, Wang J. Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma. BMC Cancer 2011; 5(11):91.
51. Palmer CN, Doney AS, Lee SP, et al. Glutathione S-Transferase M1 and P1 Genotype, Passive Smoking, and Peak Expiratory Flow in Asthma. Pediatrics 2006; 118:710-716.
52. Islam T, Berhane K, McConnell R, et al. Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 2009; 64(3):197-202.
53. Fennell TR, MacNeela JP, Morris RW, Watson M, Thompson CL, Bell DA. Hemoglobin Adducts from Acrylonitrile and Ethylene Oxide in Cigarette Smokers: Effects of Glutathione S-Transferase T1-Null and M1-Null Genotypes. Cancer Epidemiology, Biomarkers & Prevention 2000; 9: 705-712.
54. Ketelslegers HB, Gottschalk RW, Godschalk RW, Knaapen AM, van Schooten FJ, Vlietinck RF, Kleinjans JC, van Delft JH. Interindividual Variations in DNA Adduct Levels Assessed by Analysis of Multiple Genetic Polymorphisms in Smokers. Cancer Epidemiol Biomarkers Prev 2006; 15(4):624-9.
55. Yamin C, Duarte JA, Oliveira JM, et al. IL6 (-174) and TNFA (-308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exercise. Eur J Appl Physiol 2008; 104(3):579-86.
56. Wang Q, Hunt SC, Xu Q, et al. Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol 2006; 291(6):H2752-7.
57. Almeida OP, Norman PE, Allcock R, et al. Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 2009; 38(4):1049-59.
58. Lee CC, You NC, Song Y, et al. Relation of Genetic Variation in the Gene Coding for C-Reactive Protein with its Plasma Protein Concentrations: Findings from the Women's Health Initiative Observational Cohort. Clin Chem 2009; 55(2): 351-360.
59. Coppinn H, Bensaid M, Fruchon S, Borot N, Blanché H, Roth MP. Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians. BMJ 2003; 327(7407): 132-133.
60. Chicharro J, Hoyos J, Gomez-Gallego F, et al. Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes. Br J Sports Med 2004; 38(4): 418-421.
61. North K.N. ACTN3 Genotype Screen for Athletic Performance. WO04024947A1, 2004.